Peter M Sadow Selected Research

Peter M Sadow Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 01/2008
23	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 09/2009
11	Papillary Thyroid Cancer 12/2020 - 07/2012
10	Carcinoma (Carcinomatosis) 01/2022 - 01/2008
9	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2008
7	Anaplastic Thyroid Carcinoma 10/2020 - 01/2008
4	Inflammation (Inflammations) 10/2022 - 08/2013
4	Thyroid Nodule (Nodule, Thyroid) 01/2022 - 04/2013
3	Rhinosinusitis 10/2022 - 08/2013
3	medullary Thyroid cancer 10/2021 - 08/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 12/2013
3	Tuberous Sclerosis (Bourneville's Disease) 01/2020 - 07/2014
3	Lymphatic Metastasis 01/2020 - 12/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2010
2	Nasal Polyps (Nasal Polyp) 10/2022 - 08/2013
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 11/2020
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2022 - 01/2013
2	Necrosis 12/2021 - 09/2009
2	Carcinogenesis 06/2021 - 01/2020
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020 - 12/2018
2	Angiomyolipoma 01/2020 - 10/2013
2	Cachexia 10/2016 - 02/2012
2	Pheochromocytoma 01/2016 - 01/2008
2	Paraganglioma (Paragangliomas) 10/2013 - 01/2008
2	Prostatic Neoplasms (Prostate Cancer) 03/2009 - 03/2009
2	Cushing Syndrome 12/2008 - 11/2008
2	Hypothyroidism 08/2005 - 05/2003
1	Neoplasms, Cystic, Mucinous, and Serous 12/2022
1	Allergic Rhinitis 10/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022
1	Oropharyngeal Neoplasms 01/2022
1	Parathyroid Diseases (Parathyroid Disorders) 01/2022
1	Nasopharyngeal Carcinoma 11/2021
1	Hamartoma 01/2020
1	Merkel Cell Carcinoma 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 11/2020 - 12/2011
7	Biological ProductsIBA 09/2020 - 11/2008
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 12/2015 - 01/2013
4	Phosphotransferases (Kinase)IBA 10/2021 - 11/2020
4	PLX 4720IBA 06/2014 - 01/2011
3	Thyroglobulin FDA Link 10/2022 - 01/2018
3	AntibodiesIBA 01/2022 - 04/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 06/2021 - 03/2009
3	trans-sodium crocetinate (crocetin)IBA 01/2020 - 07/2014
2	prolinedithiocarbamate (PDTC)IBA 12/2020 - 09/2009
2	IntegrinsIBA 01/2020 - 01/2013
2	lipoarabinomannan (LAM)IBA 01/2020 - 12/2018
2	VemurafenibIBA 12/2018 - 12/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2018 - 07/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017 - 08/2013
2	RacivirIBA 01/2017 - 11/2015
2	Oncogene Proteins (Oncogene Protein)IBA 10/2016 - 02/2012
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 07/2014 - 10/2013
2	angiogeninIBA 03/2009 - 03/2009
1	MucinsIBA 12/2022
1	CystatinsIBA 10/2022
1	Keratin-7 (Cytokeratin 7)IBA 10/2022
1	Salivary CystatinsIBA 10/2022
1	Circulating Tumor DNAIBA 01/2022
1	oil red OIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2022
1	ChromatinIBA 12/2021
1	somatostatin receptor 2IBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 06/2021
1	OMS 2017IBA 03/2021
1	Tyrosine (L-Tyrosine)FDA Link 11/2020
1	TOR Serine-Threonine KinasesIBA 11/2020
1	Monoclonal AntibodiesIBA 10/2020
1	spartalizumabIBA 10/2020
1	human ERBB2 proteinIBA 10/2020
1	Iodine-131IBA 01/2020
1	selpercatinibIBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	Lysophosphatidic Acid ReceptorsIBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	AntigensIBA 01/2020
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2018
1	Cytostatic AgentsIBA 12/2018
1	LigandsIBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018
1	Sirolimus (Rapamycin)FDA Link 12/2018
1	Sorafenib (BAY 43-9006)FDA Link 12/2018
1	MTOR InhibitorsIBA 12/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018

Therapy/Procedure

23	Therapeutics 01/2022 - 08/2005
6	Thyroidectomy 01/2020 - 06/2010
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2010
3	Radiotherapy 01/2020 - 01/2010
2	Neck Dissection (Radical Neck Dissection) 08/2015 - 01/2010
1	Orchiectomy (Orchidectomy) 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Immunotherapy 11/2020
1	Precision Medicine 11/2020